Related Experiment Video
Updated: Jun 17, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Cell membrane patches transfer CAR molecules from a cellular depot to conventional T cells for constructing
Jing Hu1,2, Luyi Zhong1, Yiqiu Wang1,2
1School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Abstract:
Chimeric antigen receptor (CAR) serves as the foundational element of CAR-T cells. Exogenous CAR molecules can exert functional effects on allogeneic T cells, leading to their activation and subsequent functional alterations. Here we show a new method based on this biological principle: the transfer of CAR molecules from exogenous cells to the membrane of receptor T cells. This process facilitates receptor T cell to recognize target antigens and induces their activation. These patches imbued normal T cells with enhanced tumor targeting capabilities and activated their inherent killing functions. This method's efficacy introduces an approach for constructing non-genetically manipulated CAR-T cells and holds potential for application to other immune cells.
Related Concept Videos
Tumor Immunotherapy
Methods of Nuclear Reprogramming
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

